{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:12:19Z","timestamp":1792789939276,"version":"4.5.0"},"reference-count":190,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejim.2024.07.014","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T03:58:58Z","timestamp":1721361538000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Exploring the nexus: The place of kidney diseases within the cardiovascular-kidney-metabolic syndrome spectrum"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-0675","authenticated-orcid":false,"given":"Mehmet","family":"Kanbay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Guldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasin","family":"Ozbek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidar","family":"Copur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea Simona","family":"Covic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2024.07.014_bib0001","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2024.07.014_bib0002","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","article-title":"The global burden of metabolic disease: data from 2000 to 2019","volume":"35","author":"Chew","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.ejim.2024.07.014_bib0003","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0004","doi-asserted-by":"crossref","first-page":"e13878","DOI":"10.1111\/eci.13878","article-title":"The risk for chronic kidney disease in metabolically healthy obese patients: a systematic review and meta-analysis","volume":"53","author":"Kanbay","year":"2023","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejim.2024.07.014_bib0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.trsl.2016.12.004","article-title":"The metabolic syndrome and chronic kidney disease","volume":"183","author":"Zhang","year":"2017","journal-title":"Transl Res"},{"key":"10.1016\/j.ejim.2024.07.014_bib0006","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1159\/000518111","article-title":"Metabolic syndrome, and not obesity, is associated with chronic kidney disease","volume":"52","author":"Ciardullo","year":"2021","journal-title":"Am J Nephrol"},{"issue":"A7","key":"10.1016\/j.ejim.2024.07.014_bib0007","first-page":"e1","article-title":"United States Renal Data System 2011 Annual Data Report: atlas of chronic kidney disease & end-stage renal disease in the United States","volume":"59","author":"Collins","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2024.07.014_bib0008","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/HYPERTENSIONAHA.110.150722","article-title":"Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States","volume":"55","author":"Crews","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2024.07.014_bib0009","first-page":"130","article-title":"Hypertensive kidney disease: a true epidemic or rare disease?","volume":"130","author":"Stomp\u00f3r","year":"2020","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.ejim.2024.07.014_bib0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/jhh.2013.55","article-title":"Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage","volume":"28","author":"Mennuni","year":"2014","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ejim.2024.07.014_bib0011","unstructured":"NHANES. Trends in Prevalence of CKD among U.S. Adults with Hypertension. 2023.Link: https:\/\/nccd.cdc.gov\/CKD\/detail.aspx?Qnum=Q764&topic=4 (Accessed on 16 July 2024)."},{"key":"10.1016\/j.ejim.2024.07.014_bib0012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrneph.2010.154","article-title":"Epidemiology of hypertensive kidney disease","volume":"7","author":"Udani","year":"2011","journal-title":"Nature Rev Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0013","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/01.HYP.25.4.587","article-title":"Early predictors of 15-year end-stage renal disease in hypertensive patients","volume":"25","author":"Perry","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2024.07.014_bib0014","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1186\/s13104-019-4610-8","article-title":"Prevalence and associated factors of chronic kidney disease among adult hypertensive patients in Tigray teaching hospitals: a cross-sectional study","volume":"12","author":"Bahrey","year":"2019","journal-title":"BMC Res Notes"},{"issue":"Suppl 1","key":"10.1016\/j.ejim.2024.07.014_bib0015","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ndt\/16.suppl_1.70","article-title":"Prevalence of hypertension in renal disease","volume":"16","author":"Ridao","year":"2001","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.ejim.2024.07.014_bib0016","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: effects on the cardiovascular system","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2024.07.014_bib0017","first-page":"2248","article-title":"Quantitative analysis of the pathophysiology of hypertension. 1969","volume":"10","author":"Guyton","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0018","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1046\/j.1523-1755.2003.00273.x","article-title":"Role of excess volume in the pathophysiology of hypertension in chronic kidney disease","volume":"64","author":"Vasavada","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejim.2024.07.014_bib0019","first-page":"399","article-title":"Pathophysiology of hypertension in chronic kidney disease","volume":"67","author":"Sawicka","year":"2014","journal-title":"Wiad Lek"},{"issue":"Suppl 15","key":"10.1016\/j.ejim.2024.07.014_bib0020","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1681\/ASN.V11suppl_1s1","article-title":"Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0021","doi-asserted-by":"crossref","first-page":"iii62","DOI":"10.1093\/ndt\/gfh1018","article-title":"Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade","volume":"19","author":"Campistol","year":"2004","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.ejim.2024.07.014_bib0022","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000045184","article-title":"Hypertension in the transplanted patient","volume":"80","author":"Zeier","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.ejim.2024.07.014_bib0023","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0041-1345(98)00043-8","article-title":"Incidence of posttransplant hypertension among renal allograft recipients","volume":"30","author":"Malek-Hosseini","year":"1998","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejim.2024.07.014_bib0024","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0041-1345(96)00066-8","article-title":"Hypertension in patients after renal transplantation","volume":"29","author":"Budde","year":"1997","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejim.2024.07.014_bib0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fmed.2020.00229","article-title":"Approach and management of hypertension after kidney transplantation","volume":"7","author":"Tantisattamo","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ejim.2024.07.014_bib0026","doi-asserted-by":"crossref","first-page":"167","DOI":"10.33549\/physiolres.933332","article-title":"Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension","volume":"66","author":"Ho\u0161kov\u00e1","year":"2017","journal-title":"Physiol Res"},{"key":"10.1016\/j.ejim.2024.07.014_bib0027","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/jlts.2000.9737","article-title":"Posttransplantation hypertension related to calcineurin inhibitors","volume":"6","author":"Textor","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ejim.2024.07.014_bib0028","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5301\/jn.5000174","article-title":"Pathogenesis of calcineurin inhibitor-induced hypertension","volume":"25","author":"Hoorn","year":"2012","journal-title":"J Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0029","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/TP.0b013e31825f0fbe","article-title":"The pathophysiology of endothelin in complications after solid organ transplantation: a potential novel therapeutic role for endothelin receptor antagonists","volume":"94","author":"Raina","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.07.014_bib0030","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1365-2362.2011.02517.x","article-title":"Cyclosporine metabolic side effects: association with the WNK4 system","volume":"41","author":"Melnikov","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejim.2024.07.014_bib0031","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/ndt\/gfr679","article-title":"How calcineurin inhibitors cause hypertension","volume":"27","author":"Luft","year":"2011","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.ejim.2024.07.014_bib0032","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/nm.2497","article-title":"The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension","volume":"17","author":"Hoorn","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.ejim.2024.07.014_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e3181c518cc","article-title":"Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis","volume":"89","author":"Knight","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.07.014_bib0034","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00467-018-4069-1","article-title":"Steroid withdrawal improves blood pressure control and nocturnal dipping in pediatric renal transplant recipients: analysis of a prospective, randomized, controlled trial","volume":"34","author":"H\u00f6cker","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/ckj\/sfu132","article-title":"Transplant renal artery stenosis: clinical manifestations, diagnosis and therapy","volume":"8","author":"Chen","year":"2014","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ejim.2024.07.014_bib0036","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.0000000000000439","article-title":"Effect of spironolactone on kidney function in kidney transplant recipients: a randomized placebo-controlled clinical trial","author":"Mortensen","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2022.100087","article-title":"Risk factors of transplant renal artery stenosis in kidney transplant recipients","volume":"77","author":"Kanhouche","year":"2022","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.ejim.2024.07.014_bib0038","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1159\/000242431","article-title":"Predictors and outcomes of transplant renal artery stenosis after kidney transplantation: analysis of USRDS","volume":"30","author":"Hurst","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ejim.2024.07.014_bib0039","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ki.2013.181","article-title":"LDL cholesterol in CKD\u2013to treat or not to treat?","volume":"84","author":"Massy","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2024.07.014_bib0040","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00375.2015","article-title":"Systemic and renal lipids in kidney disease development and progression","volume":"310","author":"Wahl","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0041","doi-asserted-by":"crossref","first-page":"88","DOI":"10.14797\/mdcj-15-1-88","article-title":"Lipids and renal disease","volume":"15","author":"Shah","year":"2019","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.ejim.2024.07.014_bib0042","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000170146","article-title":"Hyperlipidemia of chronic renal failure","volume":"12","author":"Kaysen","year":"1994","journal-title":"Blood Purif"},{"key":"10.1016\/j.ejim.2024.07.014_bib0043","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.kint.2016.02.026","article-title":"Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences","volume":"90","author":"Vaziri","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2024.07.014_bib0044","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1053\/ajkd.1998.v32.pm9820472","article-title":"Hyperlipidemia in patients with chronic renal disease","volume":"32","author":"Kasiske","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2024.07.014_bib0045","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2014.31","article-title":"KDIGO clinical practice guideline for lipid management in CKD: summary of recommendation statements and clinical approach to the patient","volume":"85","author":"Wanner","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2024.07.014_bib0046","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2024.07.014_bib0047","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2024.07.014_bib0048","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2024.07.014_bib0049","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2213-8587(16)30156-5","article-title":"Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials","volume":"4","author":"Herrington","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0050","first-page":"49","article-title":"Hyperlipidemia after kidney transplantation: long-term graft outcome","volume":"6","author":"Raees-Jalali","year":"2012","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.ejim.2024.07.014_bib0051","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1681\/ASN.V77971","article-title":"Post-transplant hyperlipidemia: mechanisms and management","volume":"7","author":"Massy","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0052","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1034\/j.1600-6143.2002.20902.x","article-title":"Cardiovascular toxicities of immunosuppressive agents","volume":"2","author":"Miller","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ejim.2024.07.014_bib0053","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1023\/B:DDAS.0000011598.15105.58","article-title":"Everolimus\/cyclosporine interactions on bile flow and biliary excretion of bile salts and cholesterol in rats","volume":"49","author":"Deters","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ejim.2024.07.014_bib0054","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/00007890-199405270-00014","article-title":"Relation of cyclosporine blood levels to adverse effects on lipoproteins","volume":"57","author":"Kuster","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.07.014_bib0055","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1172\/JCI61919","article-title":"Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice","volume":"122","author":"Ai","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2024.07.014_bib0056","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.abb.2007.06.029","article-title":"Insulin inhibition of apolipoprotein B mRNA translation is mediated via the PI-3 kinase\/mTOR signaling cascade but does not involve internal ribosomal entry site (IRES) initiation","volume":"465","author":"Sidiropoulos","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.ejim.2024.07.014_bib0057","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/ndt\/gfr238","article-title":"Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study","volume":"27","author":"Claes","year":"2011","journal-title":"Nephrol Dialysis Transpl"},{"key":"10.1016\/j.ejim.2024.07.014_bib0058","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1111\/j.1600-6143.2005.01105.x","article-title":"Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study","volume":"5","author":"Holdaas","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ejim.2024.07.014_bib0059","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2024.07.014_bib0060","article-title":"HMG CoA reductase inhibitors (statins) for kidney transplant recipients","author":"Palmer","year":"2014","journal-title":"Cochrane Database Systematic Rev"},{"key":"10.1016\/j.ejim.2024.07.014_bib0061","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIR.0b013e31823eb07a","volume":"126","author":"Lentine","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2024.07.014_bib0062","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.15585\/mmwr.mm6643a2","article-title":"Incidence of End-Stage renal disease attributed to diabetes among persons with diagnosed diabetes - United States and Puerto Rico, 2000-2014","volume":"66","author":"Burrows","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ejim.2024.07.014_bib0063","doi-asserted-by":"crossref","DOI":"10.17267\/2675-021Xevidence.2023.e4060","article-title":"Prevalence of Diabetes Mellitus among individuals with chronic kidney disease: systematic review and meta-analysis","volume":"5","author":"Borges","year":"2023","journal-title":"J Evid-Based Healthcare"},{"key":"10.1016\/j.ejim.2024.07.014_bib0064","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.ASN.0000046029.53933.09","article-title":"Insulin resistance and risk of chronic kidney disease in nondiabetic US adults","volume":"14","author":"Chen","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0065","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1093\/ndt\/gfq817","article-title":"Correlates of insulin resistance in older individuals with and without kidney disease","volume":"26","author":"Landau","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2024.07.014_bib0066","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMc2207018","article-title":"Incidence of chronic kidney disease among adults with diabetes, 2015-2020","volume":"387","author":"Tuttle","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2024.07.014_bib0067","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ki.1997.360","article-title":"Insulin resistance in adult polycystic kidney disease","volume":"52","author":"Vareesangthip","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2024.07.014_bib0068","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1046\/j.1523-1755.1998.00898.x","article-title":"Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease","volume":"53","author":"Fliser","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2024.07.014_bib0069","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/ki.2013.9","article-title":"White adipose tissue overproduces the lipid-mobilizing factor zinc \u03b12-glycoprotein in chronic kidney disease","volume":"83","author":"Pelletier","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2024.07.014_bib0070","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1152\/ajpendo.1991.261.1.E87","article-title":"Muscle insulin resistance in uremic humans: glucose transport, glucose transporters, and insulin receptors","volume":"261","author":"Friedman","year":"1991","journal-title":"Am J Physiol-Endocrinol Metabol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0071","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1172\/JCI110067","article-title":"Insulin resistance in uremia","volume":"67","author":"DeFronzo","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2024.07.014_bib0072","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/ki.2015.305","article-title":"Molecular mechanisms of insulin resistance in chronic kidney disease","volume":"88","author":"Thomas","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2024.07.014_bib0073","doi-asserted-by":"crossref","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","article-title":"Insulin resistance in chronic kidney disease: a systematic review","volume":"311","author":"Spoto","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0074","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/TP.0b013e3181af1f53","article-title":"Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation","volume":"88","author":"Valderhaug","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.07.014_bib0075","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/ndt\/gfm011","article-title":"Diabetes mellitus after kidney transplantation: a French multicentre observational study","volume":"22","author":"Kamar","year":"2007","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.ejim.2024.07.014_bib0076","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/tri.12907","article-title":"The impact of kidney transplantation on insulin sensitivity","volume":"30","author":"J\u00f8rgensen","year":"2017","journal-title":"Transpl Int"},{"key":"10.1016\/j.ejim.2024.07.014_bib0077","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1600-6143.2004.00591.x","article-title":"Development of diabetes mellitus following kidney transplantation: a Canadian experience","volume":"4","author":"Gourishankar","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ejim.2024.07.014_bib0078","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.transproceed.2008.03.018","article-title":"Posttransplant diabetes mellitus: incidence and risk factors","volume":"40","author":"Mazali","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ejim.2024.07.014_bib0079","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00007890-199102000-00014","article-title":"Diabetes mellitus after renal transplantation in the cyclosporine era\u2013an analysis of risk factors","volume":"51","author":"Sumrani","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.07.014_bib0080","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s10157-021-02029-4","article-title":"Impact of visceral fat area in patients with chronic kidney disease","volume":"25","author":"Manabe","year":"2021","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0081","article-title":"Association of intraabdominal fat with the risk of incident chronic kidney disease according to body mass index among Korean adults","volume":"18","author":"Lee","year":"2023","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejim.2024.07.014_bib0082","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ekir.2017.01.010","article-title":"Bariatric surgery and kidney-related outcomes","volume":"2","author":"Chang","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ejim.2024.07.014_bib0083","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1681\/ASN.2005111241","article-title":"Increasing body mass index and obesity in the incident ESRD population","volume":"17","author":"Kramer","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0084","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.ki.5002586","article-title":"Association between obesity and kidney disease: a systematic review and meta-analysis","volume":"73","author":"Wang","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2024.07.014_bib0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/osp4.629","article-title":"Obesity and chronic kidney disease: a current review","volume":"9","author":"Nawaz","year":"2023","journal-title":"Obes Sci Pract"},{"key":"10.1016\/j.ejim.2024.07.014_bib0086","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.tem.2010.01.009","article-title":"Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity","volume":"21","author":"Unger","year":"2010","journal-title":"Trend Endocrinol Metab"},{"key":"10.1016\/j.ejim.2024.07.014_bib0087","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/IJNRD.S39739","article-title":"Obesity, hypertension, and chronic kidney disease","volume":"7","author":"Hall","year":"2014","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.ejim.2024.07.014_bib0088","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1159\/000313363","article-title":"Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease","volume":"31","author":"Siragy","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0089","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MNH.0b013e3283374c09","article-title":"Scope and mechanisms of obesity-related renal disease","volume":"19","author":"Hunley","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ejim.2024.07.014_bib0090","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","article-title":"Adipocytes produce aldosterone through calcineurin-dependent signaling pathways","volume":"59","author":"Briones","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2024.07.014_bib0091","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00109-008-0343-1","article-title":"Aldosterone in salt-sensitive hypertension and metabolic syndrome","volume":"86","author":"Fujita","year":"2008","journal-title":"J Mol Med"},{"key":"10.1016\/j.ejim.2024.07.014_bib0092","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1210\/jcem.84.10.5999","volume":"84","author":"Ozata","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2024.07.014_bib0093","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/01.HYP.31.1.409","article-title":"Chronic leptin infusion increases arterial pressure","volume":"31","author":"Shek","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2024.07.014_bib0094","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000499486","article-title":"Consequences of glomerular hyperfiltration: the role of physical forces in the pathogenesis of chronic kidney disease in diabetes and obesity","volume":"143","author":"Chagnac","year":"2019","journal-title":"Nephron"},{"key":"10.1016\/j.ejim.2024.07.014_bib0095","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1681\/ASN.2020101472","article-title":"Management of obesity in adults with CKD","volume":"32","author":"Friedman","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0096","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pcad.2013.10.005","article-title":"Obesity paradox in end-stage kidney disease patients","volume":"56","author":"Park","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ejim.2024.07.014_bib0097","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ekir.2017.01.009","article-title":"The obesity paradox in kidney disease: how to reconcile it with obesity management","volume":"2","author":"Kalantar-Zadeh","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ejim.2024.07.014_bib0098","first-page":"105","article-title":"Impact of transition in metabolic health and obesity on the incident chronic kidney disease: a nationwide cohort study","author":"Cho","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2024.07.014_bib0099","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.1152\/ajpendo.00179.2022","article-title":"Obesity and chronic kidney disease","volume":"324","author":"Jiang","year":"2023","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ejim.2024.07.014_bib0100","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/ajkd.2003.50059","article-title":"Demographics and trends in overweight and obesity in patients at time of kidney transplantation","volume":"41","author":"Friedman","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2024.07.014_bib0101","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/00007890-199310000-00008","article-title":"Factors influencing weight gain after renal transplantation","volume":"56","author":"Johnson","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.07.014_bib0102","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/ajkd.2003.50059","article-title":"Demographics and trends in overweight and obesity in patients at time of kidney transplantation","volume":"41","author":"Friedman","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2024.07.014_bib0103","first-page":"138","article-title":"Weight gain after kidney transplant","volume":"14","author":"Aksoy","year":"2016","journal-title":"Exp Clin Transpl"},{"key":"10.1016\/j.ejim.2024.07.014_bib0104","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1526924816681007","article-title":"Characterization of body composition and fat mass distribution 1 year after kidney transplantation","volume":"27","author":"Pantik","year":"2017","journal-title":"Prog Transpl"},{"key":"10.1016\/j.ejim.2024.07.014_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268044","article-title":"Weight gain after renal transplant: incidence, risk factors, and outcomes","volume":"17","author":"Altheaby","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejim.2024.07.014_bib0106","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.transproceed.2015.04.028","article-title":"Increase in body mass index after renal transplantation","volume":"47","author":"Uysal","year":"2015","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejim.2024.07.014_bib0107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243394","article-title":"Risk factors associated with weight gain after kidney transplantation: a cohort study","volume":"15","author":"Forte","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejim.2024.07.014_bib0108","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.transproceed.2014.05.027","article-title":"Post-transplantation weight gain: prevalence and the impact of steroid-free therapy","volume":"46","author":"de Oliveira","year":"2014","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.ejim.2024.07.014_bib0109","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fpsyt.2020.00399","article-title":"Obesity after kidney transplantation-results of a KTx360\u00b0substudy","volume":"11","author":"N\u00f6hre","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.ejim.2024.07.014_bib0110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1432-2277.2003.tb00304.x","article-title":"Weight changes after renal transplantation: a comparison between patients on 5-mg maintenance steroid therapy and those on steroid-free immunosuppressive therapy","volume":"16","author":"van den Ham","year":"2003","journal-title":"Transpl Int"},{"key":"10.1016\/j.ejim.2024.07.014_bib0111","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0899-9007(01)00723-7","article-title":"Predictors of weight gain and cardiovascular risk in a cohort of racially diverse kidney transplant recipients","volume":"18","author":"Baum","year":"2002","journal-title":"Nutrition"},{"key":"10.1016\/j.ejim.2024.07.014_bib0112","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.ekir.2021.04.009","article-title":"A narrative review of dietary approaches for kidney transplant patients","volume":"6","author":"Goldfarb Cyrino","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ejim.2024.07.014_bib0113","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2215\/CJN.08960718","article-title":"Plant-based diets in CKD","volume":"14","author":"Clegg","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0114","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2215\/CJN.12391018","article-title":"Plant-based diets and incident CKD and kidney function","volume":"14","author":"Kim","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0115","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MNH.0000000000000757","article-title":"Nutritional and dietary interventions to prolong renal allograft survival after kidney transplantation","volume":"31","author":"Tantisattamo","year":"2022","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.ejim.2024.07.014_bib0116","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1079\/BJN20051374","article-title":"Elements of Mediterranean diet improve oxidative status in blood of kidney graft recipients","volume":"93","author":"Stachowska","year":"2005","journal-title":"Br J Nutr"},{"key":"10.1016\/j.ejim.2024.07.014_bib0117","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.numecd.2014.03.003","article-title":"Mediterranean dietary pattern, inflammation and endothelial function: a systematic review and meta-analysis of intervention trials","volume":"24","author":"Schwingshackl","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.ejim.2024.07.014_bib0118","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2215\/CJN.06710619","article-title":"Mediterranean style diet and kidney function loss in kidney transplant recipients","volume":"15","author":"Gomes-Neto","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0119","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12882-017-0709-0","article-title":"Lifestyle intervention to improve quality of life and prevent weight gain after renal transplantation: design of the Active Care after Transplantation (ACT) randomized controlled trial","volume":"18","author":"Klaassen","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0120","doi-asserted-by":"crossref","first-page":"e59962","DOI":"10.1371\/journal.pone.0059962","article-title":"Expression levels of obesity-related genes are associated with weight change in kidney transplant recipients","volume":"8","author":"Cashion","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejim.2024.07.014_bib0121","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1210\/jc.2010-1575","article-title":"Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response","volume":"96","author":"Klimc\u00e1kov\u00e1","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2024.07.014_bib0122","doi-asserted-by":"crossref","first-page":"e3437","DOI":"10.1002\/dmrr.3437","article-title":"Association between metabolic syndrome and incident chronic kidney disease among Chinese: a nation-wide cohort study and updated meta-analysis","volume":"37","author":"Wu","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.ejim.2024.07.014_bib0123","doi-asserted-by":"crossref","first-page":"e13201","DOI":"10.1111\/ijcp.13201","article-title":"Shab-Bidar S. Metabolic syndrome and its components are associated with increased chronic kidney disease risk: evidence from a meta-analysis on 11 109 003 participants from 66 studies","author":"Alizadeh","year":"2018","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ejim.2024.07.014_bib0124","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1159\/000488829","article-title":"Metabolic syndrome severity and risk of CKD and worsened GFR: the Jackson Heart Study","volume":"43","author":"DeBoer","year":"2018","journal-title":"Kidney Blood Pressure Res"},{"key":"10.1016\/j.ejim.2024.07.014_bib0125","doi-asserted-by":"crossref","first-page":"e13646","DOI":"10.1111\/eci.13646","article-title":"Metabolic syndrome severity score and the progression of CKD","volume":"52","author":"Wu","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejim.2024.07.014_bib0126","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejim.2023.02.025","article-title":"Metabolically healthy obesity: misleading phrase or healthy phenotype?","volume":"111","author":"Tanriover","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2024.07.014_bib0127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196332","article-title":"The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: a nationwide study","volume":"13","author":"Kittiskulnam","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejim.2024.07.014_bib0128","article-title":"Metabolic syndrome-related kidney injury: a review and update","volume":"13","author":"Lin","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ejim.2024.07.014_bib0129","first-page":"782","article-title":"Consequences of morbid obesity on the kidney. Where are we going?","volume":"9","author":"Navarro D\u00edaz","year":"2016","journal-title":"NDT Plus"},{"key":"10.1016\/j.ejim.2024.07.014_bib0130","first-page":"175","article-title":"Simple obesity and renal function","volume":"68","author":"Sikorska","year":"2017","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0131","doi-asserted-by":"crossref","first-page":"682","DOI":"10.33594\/000000248","article-title":"Acid loading unmasks glucose homeostatic instability in proximal-tubule-targeted insulin\/insulin-like-growth-factor-1 receptor dual knockout mice","volume":"54","author":"Aljaylani","year":"2020","journal-title":"Cell Physiol Biochem: Int J Exp Cell Physiol, Biochem Pharmacol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0132","article-title":"FBXW7 mediates high glucose\u2011induced SREBP\u20111 expression in renal tubular cells of diabetic nephropathy under PI3K\/Akt pathway regulation","volume":"23","author":"Li","year":"2021","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.ejim.2024.07.014_bib0133","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13098-021-00779-5","article-title":"Association of metabolic syndrome traits with urinary biomarkers in Japanese adults","volume":"14","author":"Kabasawa","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.ejim.2024.07.014_bib0134","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jdi.13337","article-title":"Serum growth differentiation factor 11 is closely related to metabolic syndrome in a Chinese cohort","volume":"12","author":"Xu","year":"2021","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.ejim.2024.07.014_bib0135","article-title":"Metabolic syndrome and Growth Differentiation Factor 15 in older adults","author":"Carballo-Casla","year":"2021","journal-title":"Geroscience"},{"issue":"Suppl 1","key":"10.1016\/j.ejim.2024.07.014_bib0136","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ajt.12019","article-title":"OPTN\/SRTR 2011 annual data report: kidney","volume":"13","author":"Matas","year":"2013","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.ejim.2024.07.014_bib0137","first-page":"ii1","article-title":"ERBP guideline on the management and evaluation of the kidney donor and recipient","volume":"28","year":"2013","journal-title":"Nephrol Dial Transpl."},{"issue":"Suppl 1","key":"10.1016\/j.ejim.2024.07.014_bib0138","doi-asserted-by":"crossref","first-page":"c209","DOI":"10.1159\/000328070","article-title":"Renal Association Clinical Practice Guideline on the assessment of the potential kidney transplant recipient","volume":"118","author":"Dudley","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.ejim.2024.07.014_bib0139","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/SLA.0b013e3181b4ee9a","article-title":"Obesity, surgical site infection, and outcome following renal transplantation","volume":"250","author":"Lynch","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejim.2024.07.014_bib0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12916-015-0340-5","article-title":"Body mass index and outcome in renal transplant recipients: a systematic review and meta-analysis","volume":"13","author":"Lafranca","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.ejim.2024.07.014_bib0141","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00007890-200201150-00013","article-title":"The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death","volume":"73","author":"Meier-Kriesche","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.07.014_bib0142","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2215\/CJN.09131010","article-title":"Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients","volume":"6","author":"Streja","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0143","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/ajt.12331","article-title":"The survival benefit of kidney transplantation in obese patients","volume":"13","author":"Gill","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ejim.2024.07.014_bib0144","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1523-1755.2003.00761.x","article-title":"Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index","volume":"63","author":"Glanton","year":"2003","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"10.1016\/j.ejim.2024.07.014_bib0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1365-2362.32.s3.3.x","article-title":"Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction","volume":"32","author":"Boden","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejim.2024.07.014_bib0146","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2796.2000.00671.x","article-title":"Adverse endothelial function and the insulin resistance syndrome","volume":"247","author":"Tooke","year":"2000","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2024.07.014_bib0147","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: pathophysiology, management, and modulation by natural compounds","volume":"11","author":"Rochlani","year":"2017","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.ejim.2024.07.014_bib0148","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ecl.2013.10.005","article-title":"Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism","volume":"43","author":"Geer","year":"2014","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ejim.2024.07.014_bib0149","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/TP.0b013e31826e592e","article-title":"Calcineurin inhibition and new-onset diabetes mellitus after transplantation","volume":"95","author":"Chakkera","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.07.014_bib0150","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transpl"},{"key":"10.1016\/j.ejim.2024.07.014_bib0151","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/ajt.14665","article-title":"Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation","volume":"18","author":"Wissing","year":"2018","journal-title":"Am J Transpl"},{"key":"10.1016\/j.ejim.2024.07.014_bib0152","first-page":"146","article-title":"Conversion from tacrolimus to cyclosporine A for new-onset diabetes after transplantation: a single-centre experience in renal transplanted patients and review of the literature","volume":"21","author":"Ghisdal","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.ejim.2024.07.014_bib0153","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1210\/er.2015-1084","article-title":"Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes","volume":"37","author":"Shivaswamy","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejim.2024.07.014_bib0154","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1530\/JOE-14-0368","article-title":"Obesity-related hypertension: possible pathophysiological mechanisms","volume":"223","author":"Van\u011b\u010dkov\u00e1","year":"2014","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0155","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1432-2277.2012.01488.x","article-title":"Investigators FTP. Clinical diagnosis of metabolic syndrome: predicting new-onset diabetes, coronary heart disease, and allograft failure late after kidney transplant","volume":"25","author":"Israni","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.ejim.2024.07.014_bib0156","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1600-6143.2004.00558.x","article-title":"Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally","volume":"4","author":"de Vries","year":"2004","journal-title":"Am J Transpl"},{"key":"10.1016\/j.ejim.2024.07.014_bib0157","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ajkd.2006.04.078","article-title":"Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation","volume":"48","author":"Porrini","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2024.07.014_bib0158","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.transproceed.2009.07.058","article-title":"Metabolic syndrome is related to long-term graft function in renal transplant recipients","volume":"41","author":"Ozdemir","year":"2009","journal-title":"Transpl Proc"},{"key":"10.1016\/j.ejim.2024.07.014_bib0159","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/TP.0b013e3181d05a90","article-title":"Abnormal glucose metabolism and metabolic syndrome in non-diabetic kidney transplant recipients early after transplantation","volume":"89","author":"Luan","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.07.014_bib0160","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.transproceed.2013.11.031","article-title":"Short-term prospective study of metabolic syndrome in renal transplant recipients","volume":"46","author":"Shu","year":"2014","journal-title":"Transpl Proc"},{"key":"10.1016\/j.ejim.2024.07.014_bib0161","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/ndt\/gfad115","article-title":"Clinical implications of changes in metabolic syndrome status after kidney transplantation: a nationwide prospective cohort study","volume":"38","author":"Lee","year":"2023","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.ejim.2024.07.014_bib0162","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","article-title":"Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies","volume":"49","author":"Gami","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0163","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/01.tp.0000266898.93894.3d","article-title":"Metabolic syndrome and atherosclerotic events in renal transplant recipients","volume":"83","author":"Courivaud","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.07.014_bib0164","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2215\/CJN.00210106","article-title":"Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose-intolerant renal transplant recipients","volume":"1","author":"Armstrong","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0165","doi-asserted-by":"crossref","first-page":"e13649","DOI":"10.1111\/obr.13649","article-title":"Association of metabolic syndrome and chronic kidney disease","volume":"25","author":"Scurt","year":"2024","journal-title":"Obes Rev"},{"key":"10.1016\/j.ejim.2024.07.014_bib0166","doi-asserted-by":"crossref","DOI":"10.1177\/10742484221146371","volume":"27","author":"Muzurovi\u0107","year":"2022","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.ejim.2024.07.014_bib0167","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/MS9.0000000000001782","article-title":"Tirzepatide, a dual incretin analog, is a boon in metabolic syndrome: an editorial","volume":"86","author":"Bardhan","year":"2024","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.ejim.2024.07.014_bib0168","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4103\/1319-2442.202786","article-title":"Prevalence of the metabolic syndrome in kidney transplant recipients: a single-center study","volume":"28","author":"Hami","year":"2017","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/j.ejim.2024.07.014_bib0169","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1590\/S0101-28002012000100003","article-title":"Prevalence of metabolic syndrome and its associated factors in renal transplant recipients","volume":"34","author":"Teixeira","year":"2012","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0170","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11255-011-9998-6","article-title":"Metabolic syndrome in chronic kidney disease and renal transplant patients in North India","volume":"44","author":"Banerjee","year":"2012","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0171","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1399-0012.2009.01194.x","article-title":"Metabolic syndrome and new onset diabetes after transplantation in kidney transplant recipients","volume":"24","author":"Luan","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ejim.2024.07.014_bib0172","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.transproceed.2015.04.037","article-title":"Relationships between metabolic syndrome, microalbuminuria, and C-reactive protein in Turkish Kidney transplant recipients","volume":"47","author":"Sipahioglu","year":"2015","journal-title":"Transpl Proc"},{"key":"10.1016\/j.ejim.2024.07.014_bib0173","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.dsx.2016.06.027","article-title":"Metabolic syndrome and new onset diabetes after kidney transplantation","volume":"11","author":"Dedinsk\u00e1","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.ejim.2024.07.014_bib0174","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/TP.0000000000002424","article-title":"Obesity and Metabolic Syndrome in Kidney Transplantation: the Role of Dietary Fructose and Systemic Endotoxemia","volume":"103","author":"Chan","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.ejim.2024.07.014_bib0175","doi-asserted-by":"crossref","first-page":"500","DOI":"10.12659\/AOT.893664","article-title":"Metabolic syndrome in thai renal transplant recipients: a multicenter study","volume":"20","author":"Ruangkanchanasetr","year":"2015","journal-title":"Ann Transpl"},{"key":"10.1016\/j.ejim.2024.07.014_bib0176","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.jrn.2008.10.002","article-title":"Metabolic syndrome after kidney transplantation","volume":"19","author":"Bellinghieri","year":"2009","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.ejim.2024.07.014_bib0177","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/ajt.12369","article-title":"Association of metabolic syndrome with kidney function and histology in living kidney donors","volume":"13","author":"Ohashi","year":"2013","journal-title":"Am J Transpl"},{"key":"10.1016\/j.ejim.2024.07.014_bib0178","first-page":"1002","article-title":"Changes in cardiometabolic risk factors and metabolic syndrome over time in living kidney donors: a retrospective cohort study","volume":"38","author":"Mart\u00edn-Alema\u00f1y","year":"2021","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.ejim.2024.07.014_bib0179","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.transproceed.2011.03.019","article-title":"Metabolic syndrome and cardiovascular disease in kidney transplantation","volume":"43","author":"Salerno","year":"2011","journal-title":"Transpl Proc"},{"key":"10.1016\/j.ejim.2024.07.014_bib0180","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5935\/0101-2800.20130049","article-title":"Evaluation of metabolic syndrome and associations with inflammation and graft function in renal transplant recipients","volume":"35","author":"de Alencastro","year":"2013","journal-title":"J Bras Nefrol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0181","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1432-2277.2012.01488.x","article-title":"Clinical diagnosis of metabolic syndrome: predicting new-onset diabetes, coronary heart disease, and allograft failure late after kidney transplant","volume":"25","author":"Israni","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.ejim.2024.07.014_bib0182","first-page":"196","article-title":"[Metabolic syndrome after kidney transplantation]","volume":"60","author":"Nedb\u00e1lkov\u00e1","year":"2014","journal-title":"Vnitr Lek"},{"key":"10.1016\/j.ejim.2024.07.014_bib0183","first-page":"379","article-title":"Prevalence of metabolic syndrome in Chinese renal transplant recipients","volume":"14","author":"Cheung","year":"2008","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.ejim.2024.07.014_bib0184","first-page":"141","article-title":"Prevalence of the metabolic syndrome in renal transplant recipients","volume":"5","author":"Elkehili","year":"2012","journal-title":"Arab J Nephrol Transplant"},{"key":"10.1016\/j.ejim.2024.07.014_bib0185","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1440-1797.2007.00791.x","article-title":"The prevalence of metabolic syndrome in Japanese renal transplant recipients","volume":"12","author":"Naganuma","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ejim.2024.07.014_bib0186","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.transproceed.2007.07.019","article-title":"Metabolic syndrome after kidney transplantation","volume":"39","author":"Faenza","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ejim.2024.07.014_bib0187","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.transproceed.2010.08.005","article-title":"Incidence and risk factors for the metabolic syndrome and posttransplant diabetes in renal transplant recipients taking tacrolimus","volume":"42","author":"P\u00e9rez-Flores","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ejim.2024.07.014_bib0188","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.trim.2008.07.003","article-title":"Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation","volume":"20","author":"Sui","year":"2008","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.ejim.2024.07.014_bib0189","first-page":"1142","article-title":"Longitudinal study of the metabolic syndrome after kidney transplantation","volume":"31","author":"Fern\u00e1ndez Castillo","year":"2014","journal-title":"Nutr Hosp"},{"key":"10.1016\/j.ejim.2024.07.014_bib0190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.transproceed.2008.10.091","article-title":"Prevalence of the metabolic syndrome in kidney transplantation","volume":"41","author":"Kishikawa","year":"2009","journal-title":"Transplant Proc"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524003091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524003091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T22:59:43Z","timestamp":1726354783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620524003091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":190,"alternative-id":["S0953620524003091"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.07.014","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the nexus: The place of kidney diseases within the cardiovascular-kidney-metabolic syndrome spectrum","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Federation of Internal Medicine. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}